Please try another search
Third research collaboration signed under strategic partnership between Novo Nordisk (NYSE:NVO) and Flagship Pioneering to develop novel treatment approaches for cardiometabolic and rare...
The company's DELVE™ Platform combines computation and high-throughput biology to systematically discover the therapeutic potential of proteins tuned through millennia of viral evolutionThe company...
Advanced MYCHELANGELO™ I trial dose escalation to Cohort 5; Presentation of additional monotherapy data and planned expansion into Phase 2 settings expected in mid-2024Presented new preclinical data...
Ben jij sinds 2021 investeerder in crypto, dan ervaar je nu de eerste crypto winter. Uit ervaring kan ik zeggen, dit is geen pretje. In 2022 heeft de crypto markt grote tegenslagen gekregen. Als...
Instrument Type
Region
Sector
Industry
Date
Category
Provider